Improved recurrence-free survival rates in patients with HCV-related hepatocellular carcinoma and sustained virological response to direct-acting antivirals

被引：0
|
作者：
Muzica, Cristina-Maria [1 ]
Trifan, Anca [1 ]
Huiban, Laura [1 ]
Stoica, Oana [1 ]
Girleanu, Irina [1 ]
Chiriac, Stefan [1 ]
Singeap, Ana-Maria [1 ]
Cojocariu, Camelia [1 ]
Cuciureanu, Tudor [1 ]
Zenovia, Sebastian [1 ]
Nastasa, Robert [1 ]
Stanciu, Carol [1 ]
机构：
[1] Grigore T Popa Univ Med & Pharm, Gastroenterol, Iasi, Romania
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI368
引用
收藏
页码：S573 / S574
页数：2
相关论文
共 50 条
  • [21] Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
    Ochi, Hironori
    Hiraoka, Atsushi
    Hirooka, Masashi
    Koizumi, Yohei
    Amano, Michiko
    Azemoto, Nobuaki
    Watanabe, Takao
    Yoshida, Osamu
    Tokumoto, Yoshio
    Mashiba, Toshie
    Yokota, Tomoyuki
    Abe, Masanori
    Michitaka, Kojiro
    Hiasa, Yoichi
    Joko, Kouji
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (01) : 90 - 100
  • [22] Impact of Sustained Virological Response to Direct Acting Antivirals on Insulin Resistance in Patients with Chronic HCV
    Elhelbawy, Mostafa G.
    Alsebaey, Ayman
    Abdel-Razek, Wael
    Hashem, Mohammed Saad
    El Shennawy, Hassan A.
    Waked, Imam
    HEPATOLOGY, 2016, 64 : 458A - 458A
  • [23] Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
    Sanchez-Azofra, Maria
    Fernandez, Inmaculada
    Garcia-Buey, Maria L.
    Dominguez-Dominguez, Lourdes
    Fernandez-Rodriguez, Conrado M.
    Mancebo, Antonio
    Bonet, Lucia
    Ryan, Pablo
    Gea, Francisco
    Diaz-Sanchez, Antonio
    Garcia-Mayor, Marian
    Martin-Carbonero, Luz
    Castillo, Pilar
    Manzano, Maria L.
    Gonzalez-Moreno, Leticia
    Pulido, Federico
    Gutierrez, Maria L.
    Moreno, Jose M.
    Garcia-Amengual, Irene M.
    Cuevas, Guillermo
    Guerrero, Antonio
    Rivero-Fernandez, Miguel
    Portales, Maria E.
    Montes, Maria L.
    Olveira, Antonio
    LIVER INTERNATIONAL, 2021, 41 (12) : 2885 - 2891
  • [24] Predictors of hepatocellular carcinoma occurrence in men with chronic hepatitis C who achieved sustained virological response with direct-acting antivirals
    Abu Shawish, W.
    Gan, K. M. L.
    Pradhan, S.
    Zhang, G.
    Connelly, C.
    Scagliotta, M.
    Ayonrinde, O.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 73 - 74
  • [25] Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response
    Luan, Chih-Hsuan
    Su, Pin-Shuo
    Chu, Chi-Jen
    Lin, Chung-Chi
    Su, Chien-Wei
    Lee, Shou-Dong
    Wang, Yuan-Jen
    Lee, Fa-Yauh
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (09) : 795 - 805
  • [26] Pro: Direct-acting antivirals are associated with occurrence and recurrence of hepatocellular carcinoma
    Trotter, James F.
    LIVER TRANSPLANTATION, 2017, 23 (12) : 1593 - 1595
  • [27] CT EVALUATION OF SKELETAL MUSCLE MASS DYNAMICS FOLLOWING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HCV-RELATED COMPENSATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS
    Mihai, Florin
    Trifan, Anca
    Stanciu, Carol
    Huiban, Laura
    Muzica, Cristina Maria
    Ursulescu, Corina Lupascu
    Negru, Dragos
    Girleanu, Irina
    Cuciureanu, Tudor
    Singeap, Ana Maria
    GASTROENTEROLOGY, 2021, 160 (06) : S792 - S792
  • [28] Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
    Kinoshita, Mizuki Nishibatake
    Minami, Tatsuya
    Tateishi, Ryosuke
    Wake, Taijiro
    Nakagomi, Ryo
    Fujiwara, Naoto
    Sato, Masaya
    Uchino, Koji
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Shiina, Shuichiro
    Koike, Kazuhiko
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 78 - 86
  • [29] The Sustained Virological Response (SVR) by Direct-acting antivirals agents (DAA) reduces portal hypertension in patients with HCV cirrhosis.
    Calvaruso, Vincenza
    Bonaccorso, Ambra
    Mogavero, Giuseppe
    Petta, Salvatore
    Bronte, Fabrizio
    Licata, Massimo
    Peralta, Sergio
    Conte, Elisabetta
    Bavetta, Maria Grazia
    Simone, Fabio
    Craxi, Antonio
    Di Marco, Vito
    HEPATOLOGY, 2017, 66 : 249A - 250A
  • [30] Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
    Struble, Kimberly
    Chan-Tack, Kirk
    Qi, Karen
    Valappil, Thamban
    Connelly, Sarah
    Mishra, Poonam
    Price, Dionne
    Murray, Jeffrey
    Birnkrant, Debra
    JOURNAL OF VIRUS ERADICATION, 2019, 5 (03) : 138 - 144
12345